Holen Sie sich die Stockscreener-App
10.79
6.42%
-0.74
Handel nachbörslich:
10.99
0.20
+1.85%
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Clearpoint Neuro Inc expected to post a loss of 20 cents a shareEarnings Preview - TradingView
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025 - marketscreener.com
How Clearpoint Neuro, Inc. (CLPT) Affects Rotational Strategy Timing - Stock Traders Daily
Weekly Trades: Can ClearPoint Neuro Inc reach all time highs this yearDip Buying & Smart Money Movement Tracker - baoquankhu1.vn
ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last? - Yahoo Finance
CM Management LLC Sells 120,000 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
How The ClearPoint Neuro (CLPT) Investment Story Is Shifting After FDA Feedback And Valuation Cut - Yahoo Finance
Trend Review: Whats the analyst consensus on ClearPoint Neuro IncWeekly Trading Summary & Accurate Intraday Trade Tips - baoquankhu1.vn
ClearPoint Neuro options imply 6.2% move in share price post-earnings - TipRanks
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026 - Bluefield Daily Telegraph
Brain navigation firm ClearPoint Neuro sets March 17 earnings call - Stock Titan
B. Riley Securities Sticks to Their Buy Rating for ClearPoint Neuro (CLPT) - The Globe and Mail
ClearPoint Neuro (NASDAQ:CLPT) Given New $18.00 Price Target at B. Riley Financial - MarketBeat
ClearPoint Neuro (CLPT) Target Price Lowered but Rating Maintained | CLPT Stock News - GuruFocus
ClearPoint Neuro price target lowered to $18 from $28 at B. Riley - TipRanks
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Journey Medical Corp (DERM) - The Globe and Mail
CLPT Technical Analysis & ETF Price Forecast - Intellectia AI
CLPT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
(CLPT) and the Role of Price-Sensitive Allocations - Stock Traders Daily
CEO-related trust at ClearPoint Neuro (CLPT) sells 19,951 shares under plan - Stock Titan
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Uncovering a Potential 91% Upside in the Medical Device Sector - DirectorsTalk Interviews
VIX Spike: Can ClearPoint Neuro Inc reach all time highs this yearEntry Point & Intraday High Probability Alerts - baoquankhu1.vn
CLPT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CLPT (NASDAQ: CLPT) Rule 144 filing lists vested RSAs/RSUs; January 10b5-1 sales - Stock Titan
CLS Q4 (Review): Low sales due to alignment discussions with ClearPoint Neuro - marketscreener.com
CLPTClearpoint Neuro Inc Latest Stock News & Market Updates - Stock Titan
Will ClearPoint Neuro Inc. be affected by tariffs2025 Retail Activity & Technical Buy Zone Confirmation - mfd.ru
CLPT (NASDAQ: CLPT) amendment lists 10b5-1 sale of 26,463 shares - Stock Titan
Published on: 2026-02-20 20:00:43 - baoquankhu1.vn
ClearPoint Neuro (CLPT) COO receives 36,818 restricted stock units in equity grant - Stock Titan
ClearPoint Neuro (CLPT) to Release Earnings on Wednesday - MarketBeat
Responsive Playbooks and the CLPT Inflection - Stock Traders Daily
Will ClearPoint Neuro Inc. stock continue upward momentumJuly 2025 PreEarnings & Risk Managed Investment Strategies - mfd.ru
Is ClearPoint Neuro Inc. stock ready for breakout2025 Bull vs Bear & Free Accurate Trade Setup Notifications - mfd.ru
Pullback Watch: What are ClearPoint Neuro Incs recent SEC filings showing2025 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT): Investor Outlook Reveals 116.90% Potential Upside In Medical Devices Sector - DirectorsTalk Interviews
Is ClearPoint Neuro Inc. stock forming a cup and handle2025 Trade Ideas & Weekly Market Pulse Updates - mfd.ru
ClearPoint Neuro shares advance after securing EU MDR approval - MSN
Essex Investment Management Co. LLC Sells 92,920 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Published on: 2026-02-07 14:18:50 - baoquankhu1.vn
Aug Big Picture: What chart patterns are forming on Cavco Industries IncDividend Hike & Growth Focused Entry Reports - baoquankhu1.vn
Earnings Risk: What is GCTSWSs valuation compared to sectorQuarterly Growth Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Understanding the Setup: (CLPT) and Scalable Risk - Stock Traders Daily
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring a 117.88% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
US Market Wrap: What are ClearPoint Neuro Incs recent SEC filings showingQuarterly Trade Review & Growth Focused Entry Point Reports - baoquankhu1.vn
ClearPoint Neuro expands team to over 170 focused on Neuro - Traders Union
Painful Week for Individual Investors Invested in ClearPoint Neuro, Inc. (NASDAQ:CLPT) After 18% Drop, Institutions Also Suffered Losses - 富途牛牛
ClearPoint Neuro (NASDAQ:CLPT shareholders incur further losses as stock declines 18% this week, taking five-year losses to 47% - simplywall.st
Published on: 2026-01-30 00:59:02 - baoquankhu1.vn
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Is A 115.93% Upside On The Horizon? - DirectorsTalk Interviews
Insider Selling: ClearPoint Neuro (NASDAQ:CLPT) CEO Sells $45,822.51 in Stock - MarketBeat
CLPT Gets EU MDR Certification for ClearPoint Navigation Software - Finviz
ClearPoint Neuro: From Validation To Scale (NASDAQ:CLPT) - Seeking Alpha
Market Review: Can NextPlat Corp Equity Warrant outperform under higher oil pricesRisk Management & Growth Focused Investment Plans - baoquankhu1.vn
Quarterly Earnings: Will Georgia Power Company Preferred Security be affected by tariffsBreakout Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
The Technical Signals Behind (CLPT) That Institutions Follow - Stock Traders Daily
ClearPoint Neuro Gets EU Green Light For Updated Brain Surgery Software - Sahm
ClearPoint Neuro receives EU MDR certification for navigation software By Investing.com - Investing.com Australia
0.66%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):